William H. Yong, MD

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Magaki S, Haeri M, Szymanski LJ, et al. (2023) Hyaline protoplasmic astrocytopathy in epilepsy. Neuropathology : Official Journal of the Japanese Society of Neuropathology
Zhang D, Yong W, Movassaghi M, et al. (2022) Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib. Biomedicines. 10
Wu X, Geng F, Cheng X, et al. (2020) Lipid Droplets Maintain Energy Homeostasis and Glioblastoma Growth via Autophagic Release of Stored Fatty Acids. Iscience. 23: 101569
Patel KS, Yao J, Raymond C, et al. (2020) Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Scientific Reports. 10: 14819
Voth BL, Pelargos PE, Barnette NE, et al. (2020) Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma. Journal of Neuro-Oncology
Patel KS, Kejriwal S, Sun MM, et al. (2020) Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. Journal of Neuro-Oncology
Zhang D, Damoiseaux R, Bergsneider M, et al. (2020) SAT-311 Role of SREBP in Regulation of Corticotroph Tumor ACTH Secretion and Cell Proliferation Journal of the Endocrine Society. 4
Molaie D, Lai A, Ellingson BM, et al. (2020) Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma. Journal of Clinical Oncology. 38: 2540-2540
Antonios JP, Everson RG, Mochizuki A, et al. (2020) Abstract PR13: Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination Cancer Immunology Research. 8
Maletkovic J, Dabbagh A, Zhang D, et al. (2019) Residual Tumor Confers a 10-Fold Increased Risk of Regrowth in Clinically Nonfunctioning Pituitary Tumors. Journal of the Endocrine Society. 3: 1931-1941